Search

everythinglearnresearchcommunity

for

Search:↓

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Finasteride improves hair growth in men with androgenetic alopecia.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Drugs that block GSK-3 show promise for treating various diseases.

Bitter melon extract may help prevent hair loss and can be used in cosmetic products.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Doctors should prescribe Minoxidil, Finasteride, and Dutasteride for treating androgenetic alopecia.

Fat cells help recruit healing cells and build skin structure during wound healing.

Trichotillomania is a chronic condition where people uncontrollably pull out their hair, often starting in childhood.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Eclipta alba L. (Urang-Aring) can help treat hair loss.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.